These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 14510254
1. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Carling P, Fung T, Killion A, Terrin N, Barza M. Infect Control Hosp Epidemiol; 2003 Sep; 24(9):699-706. PubMed ID: 14510254 [Abstract] [Full Text] [Related]
2. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals. Simor AE, Williams V, McGeer A, Raboud J, Larios O, Weiss K, Hirji Z, Laing F, Moore C, Gravel D, Community and Hospital Infection Control Association–Canada. Infect Control Hosp Epidemiol; 2013 Jul; 34(7):687-93. PubMed ID: 23739072 [Abstract] [Full Text] [Related]
3. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Kaier K, Hagist C, Frank U, Conrad A, Meyer E. Infect Control Hosp Epidemiol; 2009 Apr; 30(4):346-53. PubMed ID: 19236282 [Abstract] [Full Text] [Related]
4. Multihospital surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and Clostridium difficile: analysis of a 4-year data-sharing project, 1999-2002. Burger T, Fry D, Fusco R, Luschini M, Mayo JB, Ng V, Roye-Horn K, Wagner N. Am J Infect Control; 2006 Sep; 34(7):458-64. PubMed ID: 16945694 [Abstract] [Full Text] [Related]
5. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers. Mauldin PD, Salgado CD, Durkalski VL, Bosso JA. Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560 [Abstract] [Full Text] [Related]
6. Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance. Poduval RD, Kamath RP, Corpuz M, Norkus EP, Pitchumoni CS. Am J Gastroenterol; 2000 Dec; 95(12):3513-5. PubMed ID: 11151886 [Abstract] [Full Text] [Related]
8. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection. Miller M, Bernard L, Thompson M, Grima D, Pepin J. Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636 [Abstract] [Full Text] [Related]
9. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. Fowler S, Webber A, Cooper BS, Phimister A, Price K, Carter Y, Kibbler CC, Simpson AJ, Stone SP. J Antimicrob Chemother; 2007 May; 59(5):990-5. PubMed ID: 17387117 [Abstract] [Full Text] [Related]
11. Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Brooks S, Khan A, Stoica D, Griffith J, Friedeman L, Mukherji R, Hameed R, Schupf N. Infect Control Hosp Epidemiol; 1998 May; 19(5):333-6. PubMed ID: 9613694 [Abstract] [Full Text] [Related]
12. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A. Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [Abstract] [Full Text] [Related]
13. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S. J Antimicrob Chemother; 2008 Sep; 62(3):601-7. PubMed ID: 18468995 [Abstract] [Full Text] [Related]
14. [Antibiotics: the race continues]. Oberpichler-Schwenk H. Med Monatsschr Pharm; 2012 Sep; 35(9):311. PubMed ID: 23050347 [No Abstract] [Full Text] [Related]
15. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L. Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240 [Abstract] [Full Text] [Related]
16. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL. Infect Control Hosp Epidemiol; 2006 Feb; 27(2):155-69. PubMed ID: 16465632 [Abstract] [Full Text] [Related]
17. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program. Hacek DM, Bednarz P, Noskin GA, Zembower T, Peterson LR. J Clin Microbiol; 2001 Mar; 39(3):1152-4. PubMed ID: 11230446 [Abstract] [Full Text] [Related]
18. The continuing crisis in antibiotic resistance. French GL. Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S3-7. PubMed ID: 21129629 [Abstract] [Full Text] [Related]
19. Decrease of methicillin resistant Staphylococcus aureus prevalence after introduction of a surgical antibiotic prophylaxis protocol in an Italian hospital. Nicastri E, Leone S, Petrosillo N, Ballardini M, Pisanelli C, Magrini P, Cerquetani F, Ippolito G, Comandini E, Narciso P, Meledandri M. New Microbiol; 2008 Oct; 31(4):519-25. PubMed ID: 19123308 [Abstract] [Full Text] [Related]
20. Colonization and infection with multiple nosocomial pathogens among patients colonized with vancomycin-resistant Enterococcus. Donskey CJ, Ray AJ, Hoyen CK, Fuldauer PD, Aron DC, Salvator A, Bonomo RA. Infect Control Hosp Epidemiol; 2003 Apr; 24(4):242-5. PubMed ID: 12725351 [Abstract] [Full Text] [Related] Page: [Next] [New Search]